Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-?? ligand in patients under evaluation for differentiated thyroid carcinoma*

Human Thyroid ◽

Nuclear Factor ◽

Soluble Receptor ◽

Receptor Activator ◽

Serum osteoprotegerin and soluble receptor activator of nuclear factor κB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study

Metabolism ◽

10.1016/j.metabol.2007.01.004 ◽

2007 ◽

Vol 56 (5) ◽

pp. 699-707 ◽

Cited By ~ 3

Author(s):

Massimo Giusti ◽

Francesca Cecoli ◽

Laura Fazzuoli ◽

Vincenzina De Franchis ◽

Enrica Ceresola ◽

...

Keyword(s):

Cohort Study ◽

Thyroid Carcinoma ◽

Nuclear Factor Κb ◽

Nuclear Factor ◽

Soluble Receptor ◽

Receptor Activator ◽

History Of

Thyroid-stimulating hormone (TSH) suppression in differentiated thyroid carcinoma: Combined treatment with triiodothyronine and thyroxine

European Journal of Cancer ◽

10.1016/0959-8049(94)00428-8 ◽

1994 ◽

Vol 30 (14) ◽

pp. 2184-2185 ◽

Cited By ~ 2

Author(s):

C.L. Maini ◽

R. Sciuto ◽

A. Tofani ◽

I. Rosito ◽

G. Franciotti ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Combined Treatment ◽

Tsh Suppression ◽

Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma

Thyroid ◽

10.1089/thy.2009.0187 ◽

2010 ◽

Vol 20 (2) ◽

pp. 173-179 ◽

Cited By ~ 79

Author(s):

Jandee Lee ◽

Mee Jin Yun ◽

Kee Hyun Nam ◽

Woong Youn Chung ◽

Euy-Young Soh ◽

...

Keyword(s):

Quality Of Life ◽

Thyroid Carcinoma ◽

Low Dose ◽

Remnant Ablation ◽

Hormone Administration ◽

Radioiodine Remnant Ablation ◽

c-Kit Proto-oncogene Is More Likely to Lose Expression in Differentiated Thyroid Carcinoma Than Three Thyroid-specific Genes: Thyroid Peroxidase, Thyroglobulin, and Thyroid Stimulating Hormone Receptor.

Endocrine Journal ◽

10.1507/endocrj.42.723 ◽

1995 ◽

Vol 42 (5) ◽

pp. 723-728 ◽

Cited By ~ 10

Author(s):

TETSUJI TANAKA ◽

KAZUMI UMEKI ◽

IKUO YAMAMOTO ◽

TOMIO KOTANI ◽

FUJIO SAKAMOTO ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Hormone Receptor ◽

Thyroid Peroxidase ◽

Frontiers of Hormone Research - Growth Regulation of Thyroid Gland and Thyroid Tumors ◽

Thyroid-Stimulating Hormone Growth-Responsive, Cyclic Adenosine Monophosphate-Unresponsive Poorly Differentiated Thyroid Carcinoma of Follicular Cell Origin1

10.1159/000417503 ◽

2015 ◽

pp. 81-87 ◽

Cited By ~ 1

Author(s):

A. E. Siperstein ◽

H. van Raavenswaay Claasen ◽

R. Miller ◽

M. M. Bhattathiry ◽

M. Hughes-Fulford ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Cyclic Adenosine Monophosphate ◽

Adenosine Monophosphate ◽

Follicular Cell ◽

Poorly Differentiated Thyroid Carcinoma ◽

Poorly Differentiated ◽

The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma

Bone ◽

10.1016/j.bone.2015.10.015 ◽

2016 ◽

Vol 83 ◽

pp. 104-110 ◽

Cited By ~ 14

Author(s):

Jae Hoon Moon ◽

Kyong Yeun Jung ◽

Kyoung Min Kim ◽

Sung Hee Choi ◽

Soo Lim ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Bone Geometry ◽

Suppressive Therapy ◽

Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma

British Journal of Radiology ◽

10.1259/bjr/26733491 ◽

2012 ◽

Vol 85 (1018) ◽

pp. e805-e813 ◽

Cited By ~ 6

Author(s):

R J D Prestwich ◽

S Viner ◽

G Gerrard ◽

C N Patel ◽

A F Scarsbrook

Keyword(s):

Positron Emission Tomography ◽

Thyroid Carcinoma ◽

Emission Tomography ◽

Positron Emission ◽

A retrospective review of the management of skeletal effects following thyroid stimulating hormone suppression therapy (tshst) in patients treated for differentiated thyroid carcinoma (dtc)

Endocrine Abstracts ◽

10.1530/endoabs.73.aep118 ◽

2021 ◽

Author(s):

Deepa Beeharry ◽

Simra Ahmed ◽

Dushyant Sharma

Keyword(s):

Thyroid Carcinoma ◽

Retrospective Review ◽

Skeletal Effects ◽

Naming difficulties after thyroid stimulating hormone suppression therapy in patients with differentiated thyroid carcinoma: a prospective cohort study

Endocrine ◽

10.1007/s12020-019-01943-8 ◽

2019 ◽

Vol 65 (2) ◽

pp. 327-337 ◽

Cited By ~ 2

Author(s):

Shan Jin ◽

Yun-Tian Yang ◽

Wuyuntu Bao ◽

Yinbao Bai ◽

Jing-Wen Ai ◽

...

Keyword(s):

Cohort Study ◽

Thyroid Carcinoma ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy

Internal Medicine Journal ◽

10.1111/j.1445-5994.2006.01149.x ◽

2006 ◽

Vol 36 (9) ◽

pp. 564-570 ◽

Cited By ~ 26

Author(s):

W. F. E. Lau ◽

M. R. Zacharin ◽

K. Waters ◽

G. Wheeler ◽

V. Johnston ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Radioiodine Therapy ◽

Human Thyroid ◽

Recent Experience ◽